Lucintel Forecasts Interventional Cardiology and Peripheral Vascular Device Market to Reach $31.6 Billion by 2027

According to the recent study the interventional cardiology and peripheral vascular device market is projected to reach an estimated $31.6 billion by 2027 from $22.6 billion in 2021, at a CAGR of 5.7% from 2021 to 2027. Growth in this market is primarily driven by growing elderly population, rise in prevalence of chronic diseases, and advancements in medical technology and research.
Browse 112 figures / charts and 97 tables in this 201 -page report to understand trends, opportunities and forecast in interventional cardiology and peripheral vascular device market by type (interventional cardiology and peripheral vascular device), device (angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent graft, IVC filter, embolic protection device, guidewires, arteriotomy closure device, intravascular ultrasound system, and synthetic surgical graft), end user (hospitals and ambulatory surgical centers), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Download sample report by clicking on below link https://www.lucintel.com/interventional-cardiology-peripheral-vascular-devi.aspx

“Interventional cardiology devices market is expected to remain the largest segment during the forecast period.”
Based on type, the interventional cardiology and peripheral vascular device market is segmented into interventional cardiology and peripheral vascular device. Lucintel forecasts that the interventional cardiology devices market is expected to remain the largest segment.
“Within the interventional cardiology and peripheral vascular device market, the hospitals segment is expected to remain the largest end user”
Based on end user the hospitals segment is expected to witness the highest growth over the forecast period due to the growing public-private partnerships to improve access to healthcare services along with rapid developments in healthcare infrastructure and improving access to healthcare services.
“North America will dominate the interventional cardiology and peripheral vascular device market in near future”
North America is expected to remain the largest region because it is a large pharmaceutical manufacturing base and it is witnessing increasing technological advancements in interventional cardiology and peripheral vascular devices.
Download Brochure of this report by clicking on https://www.lucintel.com/interventional-cardiology-peripheral-vascular-devi.aspx
Major players of interventional cardiology and peripheral vascular device market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronics Public Limited Company, C. R. Bard, Inc., Cook Medical Inc., Terumo Corporation, and Cardinal Health Inc are among the major interventional cardiology and peripheral vascular device providers.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/interventional-cardiology-peripheral-vascular-devi.aspx or helpdesk@lucintel.com
read more..